Reneo Pharmaceuticals Inc’s recent filing unveils that its 10% Owner Leonard Braden Michael acquired Company’s shares for reported $0.24 million on Aug 13 ’24. In the deal valued at $1.39 per share,171,339 shares were bought. As a result of this transaction, Leonard Braden Michael now holds 2,843,533 shares worth roughly $3.73 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Leonard Braden Michael bought 100,487 shares, generating $142,008 in total proceeds. Upon buying the shares at $1.41, the 10% Owner now owns 2,944,020 shares.
Before that, Leonard Braden Michael bought 414,281 shares. Reneo Pharmaceuticals Inc shares valued at $639,578 were divested by the 10% Owner at a price of $1.54 per share. As a result of the transaction, Leonard Braden Michael now holds 2,672,194 shares, worth roughly $3.5 million.
Leerink Partners downgraded its Reneo Pharmaceuticals Inc [RPHM] rating to a Market perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Jefferies’s analysts, who decreased its forecast for the stock in mid December from “a Buy” to “a Hold”. H.C. Wainwright also remained covering RPHM and has decreased its forecast on December 15, 2023 with a “Neutral” recommendation from previously “Buy” rating. William Blair revised its rating on December 14, 2023. It rated RPHM as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of RPHM
On Friday, Reneo Pharmaceuticals Inc [NASDAQ:RPHM] saw its stock fall -7.09% to $1.31. Over the last five days, the stock has lost -8.39%. Reneo Pharmaceuticals Inc shares have fallen nearly -18.13% since the year began. Nevertheless, the stocks have fallen -80.93% over the past one year. While a 52-week high of $9.21 was reached on 06/12/24, a 52-week low of $0.98 was recorded on 09/13/24. SMA at 50 days reached $1.4708, while 200 days put it at $1.9193.
Levels Of Support And Resistance For RPHM Stock
The 24-hour chart illustrates a support level at 1.2434, which if violated will result in even more drops to 1.1768. On the upside, there is a resistance level at 1.3833. A further resistance level may holdings at 1.4566. The Relative Strength Index (RSI) on the 14-day chart is 31.53, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0762, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 86.38%. Stochastics %K at 16.76% indicates the stock is a buying.
How much short interest is there in Reneo Pharmaceuticals Inc?
A steep rise in short interest was recorded in Reneo Pharmaceuticals Inc stocks on 2024-08-30, dropping by 10159.0 shares to a total of 3.23 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-31 was 3.24 million shares. There was a decline of -0.31%, which implies that there is a negative sentiment for the stock.
